News

In a statement, the Japanese firm said that the media reports regarding Roche’s intention to own 100% of Chugai shares is not based on any announcement made by

In March 2014, Pragma acquired Moxatag from Shionogi and has been working to make the product available in time for the upcoming cold and flu season. Pragma spokesperson

Currently, AG-221 is being evaluated in a Phase I clinical trial in patients with advanced hematologic malignancies. Agios chief medical officer Dr Chris Bowden said the company believes

The company said that Plegridy is the only pegylated beta interferon approved to use in RMS, which is dosed once every two weeks. The drug can be administered

Therefore, Putian Pharmacy, as the sales agency, will be allowed to sell Huoliyuan capsules in 15 Chinese provinces, which indicates that the sales network of Huoliyuan capsules has

Accordingly, at present, seven of a total of 20 patients have been enrolled in the study. The enrollment of new patients to the study has taken somewhat longer

The open-label extension study of ISIS-SMN is offered to those children with SMA who have completed dosing in Isis’ previous studies. In this study, children with SMA are

In a May 2014 letter to Acura, FDA questioned the relevance of abuse of hydrocodone with acetaminophen products by nasal snorting after reviewing clinical and epidemiology data submitted

This product candidate is expected to enter Phase III testing, with patient dosing commencing during 2015. Fast track designation is for products that are being investigated for treatment